Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Adobe patches a critical PDF flaw exploited for months, allowing attackers to bypass sandbox protections and deliver malware.
In order to improve care for people with multiple sclerosis (MS), we need to understand more about their disease. The way we measure the impact of MS on daily life has remained relatively unchanged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results